Company Filing History:
Years Active: 1987
Title: Michel Jolivet: Innovator in Synthetic Peptide Compounds
Introduction
Michel Jolivet is a notable inventor based in Issy-les-Moulineaux, France. He has made significant contributions to the field of synthetic peptide compounds, particularly in relation to medical applications. His work has led to the development of innovative solutions that address specific health challenges.
Latest Patents
Michel Jolivet holds a patent for synthetic peptide compounds. This patent specifically involves a peptide fragment of the M protein of Streptococcus pyogenes, which elicits opsonic antibodies that are type-specific for type 24 streptococci. This invention has the potential to enhance the understanding and treatment of streptococcal infections.
Career Highlights
Jolivet is associated with the University of Tennessee Research Corporation, where he has been able to further his research and development efforts. His work in this institution has allowed him to collaborate with other experts in the field and contribute to advancements in peptide technology.
Collaborations
Some of his notable coworkers include Edwin H. Beachey and Andre Tartar. Their collaborative efforts have likely enriched the research environment and fostered innovative ideas in the realm of synthetic peptides.
Conclusion
Michel Jolivet's contributions to synthetic peptide compounds exemplify the impact of innovative research in the medical field. His patent and collaborations highlight the importance of teamwork in advancing scientific knowledge and technology.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.